Is combined estrogen/progestogen hormone therapy worth the risk?

By Sturdee David W.   MacLennan Alastair H.  

Climacteric, Vol. 6, Iss. 3, 2003-09 ,pp. : 177-179

Informa Healthcare

Access to resources Recommend Favorite

Flow resistance in carotid and middle cerebral arteries in postmenopausal women: a comparative study of tibolone and continuous combined hormone replacement therapy

By Pan H.-A.   Wang S.-T.   Chen C.-H.   Pai M.-C.   Wu M.-H.   Huang K.-E.  

Climacteric, Vol. 5, Iss. 3, 2002-09 ,pp. : 259-265

Informa Healthcare

Access to resources Recommend Favorite

Effects of tibolone and continuous combined hormone replacement therapy on parameters in the clotting cascade: a multicenter, double-blind, randomized study

By Winkler U.H.   Altkemper R.   Kwee B.   Helmond F.A.   Coelingh Bennink H.J.T.  

Fertility and Sterility, Vol. 74, Iss. 1, 2000-07 ,pp. : 10-19

Elsevier

Access to resources Recommend Favorite

Smoking reduces breast tenderness during oral estrogen-progestogen therapy

By Bjarnason NH   Jørgensen C   Kremmer H   Alexandersen P   Christiansen C  

Climacteric, Vol. 7, Iss. 4, 2004-12 ,pp. : 390-396

Informa Healthcare

Access to resources Recommend Favorite

Mammographic breast density during hormone replacement therapy: effects of continuous combination, unopposed transdermal and low-potency estrogen regimens

By Lundström E.   Wilczek B.   von Palffy Z.   Söderqvist G.   von Schoultz B.  

Climacteric, Vol. 4, Iss. 1, 2001-03 ,pp. : 42-48

Informa Healthcare

Access to resources Recommend Favorite